Delivery Order SPE2DB22D3004-SPE2DB24FQA07

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.13 firm fixed-price delivery order is for the supply of 4566747173 ! XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,067.54 firm fixed price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,009.20 fixed-price delivery order is for XYLOCAINE 2%-EPI 1:200,000 20ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This contract award is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award, valued at $1,249.07, was made to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. As a subsidiary of Amerisourcebergen Corporation, the awardee leverages its parent company's extensive supply chain network to fulfill government contracts. The contract has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,491.66 firm fixed-price delivery order contract is for the supply of XYLOCAINE 1%-EPI 1:100,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2024 and was awarded on March 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,727.07, is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication, with a completion date of January 5, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,431.84 Firm Fixed Price Delivery Order is for the supply of XYLOCAINE 1%-EPI 1:100,000 20ML, a medical product used for anesthesia. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $2,446.05 for the supply of XYLOCAINE 2%-EPI 1:200,000 20ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award, valued at $2,243.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYLOCAINE 2%-EPI 1:100,000 20ML, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQA07
    Delivery Order

This federal contract award is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The firm-fixed-price delivery order has a ceiling value of $1,096.66 and is set to expire on April 17, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/16/24, 12:16 PM